People In The News

NEW YORK (GenomeWeb News) – Former Monogram Biosciences CEO and Chairman William Young will become chairman of Biogen Idec at the beginning of 2010, when he will take over the job from Bruce Ross. Ross plans to complete his current term as director and then retire. Before he worked at Monogram, Young was COO and VP of Genentech and he worked at Eli Lilly.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.